Back
Pfizer, Inc. (PFE)
PharmaceuticalsPFE · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$23.88
−0.83%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$1.36
ROE
8.3%
Gross margin
74.8%
Debt/Equity
0.72x
Revenue growth
5.4%
Pfizer, Inc. — company intelligence
Earnings surprises
Q1 2026$0.75 vs $0.72 est+3.5%
Q4 2025$0.66 vs $0.58 est+14.3%
Q3 2025$0.87 vs $0.64 est+36.0%
Q2 2025$0.78 vs $0.59 est+32.9%
Insider activity · 90 days
17 buys1 sellnet +83,582 shares
BOURLA ALBERTBuy 23 · Jun 15, 2026
DAMICO JENNIFER B.Sell 2,000 · Jun 9, 2026
BOURLA ALBERTBuy 23 · May 29, 2026
Recent SEC filings
4 — Insider transaction reportJul 1, 2026
4 — Insider transaction reportJun 30, 2026
4 — Insider transaction reportJun 30, 2026
Latest news
Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? — Yahoo · 11h ago
Pfizer (PFE) Gets An Opening In ATTR CM After AstraZeneca Trial Failure — Yahoo · 13h ago
Sector Update: Healthcare Stocks Decline Late Afternoon — Yahoo · 15h ago
How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High — Yahoo · 18h ago
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? — Yahoo · 18h ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Pfizer, Inc.
Weekly undervalued picks (like PFE)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.